School of Medicine
Showing 1,781-1,800 of 2,422 Results
-
William H. Robinson, MD PhD
James W. Raitt, M.D. Professor
Current Research and Scholarly InterestsOur overarching objective is to elucidate the molecular and cellular mechanisms underlying autoimmune and rheumatic diseases and translate these discoveries into next-generation diagnostics and therapeutics.
-
Nancy Robles, NP-C
Affiliate, Medicine - Med/Cardiovascular Medicine
BioI'm an advanced practice provider with a focus in inherited cardiovascular disease, neuromuscular disease associated cardiomyopathies, advanced heart failure, and sports cardiology. I also have a strong background in Emergency Medicine and trauma. Hablo Espanol.
-
Stanley G. Rockson, MD
Allan and Tina Neill Professor of Lymphatic Research and Medicine
Current Research and Scholarly InterestsMy clinical research includes studies on risk factor modification in atherosclerosis and coronary artery disease; clinical trials involving medical therapies for peripheral arterial insufficiency; coronary angiogenesis; therapy of lymphedema; atherand photodynamic therapy in atherosclerosis.
-
Alexandre Rodrigues Marra
Contingent Employee, Medicine - Med/Infectious Diseases
Current Role at StanfordResearcher
-
Desirée Rodrigues Plaça
Postdoctoral Scholar, Infectious Diseases
Current Research and Scholarly InterestsI am studying Flaviviridae viruses, focusing on dengue. My research explores T cell and myeloid dysregulation in severe dengue to improve vaccines and identify biomarkers. I'm characterizing T cell responses to DENV, and the regulatory immune response through integrative systems analysis. My ultimate goal is to contribute to the development of improved diagnostic tools and vaccines for pediatric infectious diseases, particularly in endemic regions like Brazil.
-
Fatima Rodriguez
Robert and Shirley Raymer Professor
BioFatima Rodriguez, MD, MPH serves as the Vice Chair of Clinical Research (Department of Medicine), Section Chief of Preventive Cardiology, and Associate Director of the Center for Digital Health at Stanford University. She received her medical degree from Harvard Medical School and a Master of Public Health from the Harvard T.H. Chan School of Public Health. Dr. Rodriguez completed her internal medicine residency at Brigham and Women’s Hospital and fellowship in cardiovascular medicine at Stanford.
Dr. Rodriguez specializes in the prevention and management of cardiovascular disease, with clinical expertise in coronary artery disease and inherited lipid disorders. Her research focuses on cardiovascular disease prevention and health promotion, leveraging digital tools to improve guideline-based care, and using AI-enabled approaches for early detection of atherosclerosis. -
Albert "A.J." Rogers, MD, MBA, FAHA, FHRS
Assistant Professor of Medicine (Cardiovascular Medicine)
BioDr. Rogers is a board-certified, fellowship-trained cardiologist with the Cardiac Arrhythmia Service at Stanford Health Care. He is Assistant Professor of Medicine in the Division of Cardiovascular Medicine, Department of Medicine at Stanford University School of Medicine.
As a clinical cardiac electrophysiologist, Dr. Rogers’ expertise includes evaluating issues involving electrical activity in the heart and how these can lead to an abnormal heart rhythm (arrhythmia). This includes mapping regions in the heart associated with arrhythmias and then applying a minimally invasive therapy (ablation) that targets the responsible areas causing the problem. He also performs procedures to implant cardiac devices, such as pacemakers and defibrillators, designed to synchronize heart contractions and reset irregular heartbeats.
Dr. Rogers specializes in the diagnosis and treatment of atrial fibrillation, ventricular tachycardia, and other arrhythmias. In collaboration with Stanford Medicine cardiovascular surgeons, he performs hybrid surgical-catheter ablation procedures as a more permanent treatment for persistent forms of atrial fibrillation and for inappropriate sinus tachycardia. During this procedure, ablation therapy is applied to areas both inside and outside of the heart responsible for the arrhythmia.
As a physician-researcher, Dr. Rogers’ translational research applies biomedical engineering and machine learning approaches to explore the mechanisms underlying cardiac arrhythmia. These efforts include research funded by the National Institutes of Health and the American Heart Association to investigate novel methods for diagnosing and treating heart rhythm disorders. Dr. Rogers has over 15 years of experience with medical technology innovation and development.
Dr. Rogers serves as associate editor of the Journal of Invasive Cardiovascular Electrophysiology. He has been an invited guest speaker at national and international meetings, including those for the American Heart Association and the European Cardiac Arrythmia Society. -
Angela Rogers
Professor-Univ Med Line, Medicine - Pulmonary, Allergy & Critical Care Medicine
Current Research and Scholarly InterestsWe use genetics and genomics methodologies to identify novel ARDS pathobiology; we hope that this will enable identification of novel biomarkers, phenotypes, and treatments for the disease. We are building a plasma biobank of critically ill patients at Stanford, with a particular focus on metabolic changes in critical illness.
-
Nidhi Rohatgi, MD MS
Clinical Professor, Medicine
Clinical Professor (By courtesy), Neurosurgery
Clinical Professor (By courtesy), Anesthesiology, Perioperative and Pain MedicineBioNidhi Rohatgi, MD, MS, SFHM, is a Clinical Professor of Medicine and (by courtesy) Neurosurgery and Anesthesiology, Perioperative, and Pain Medicine at Stanford University School of Medicine. She is Affiliate Faculty at Stanford's Center for Artificial Intelligence in Medicine and Imaging (AIMI), Institute for Human-Center AI (HAI), and Center for Digital Health.
Dr. Rohatgi's work focuses on what makes clinical interventions, and increasingly AI, succeed or fail in real-world care. She has written on LLMs for clinical text summarization and pharmacogenomics, multimodal in-context learning (NeurIPS 2025), the promises and limitations of AI, and digital twins for surgical site infections (IISE/ANNSIM 2026). Her current interests include real-world evaluation and implementation of AI across the care continuum, and identifying where AI can improve outcomes and reduce cost. She collaborates with clinicians, engineers, health systems, and industry partners on translating AI into safe, effective clinical practice. She delivered the keynote on Engineering AI for Real Clinical Impact at the 2026 IEEE International Conference on Sustainability, Innovation, and Technology. In her upcoming book, she shares a blueprint for AI in medicine: where AI can help and how, global health AI trends, and tackling costs.
Her perspective is grounded in more than a decade of leading and scaling clinical programs at Stanford. For over 10 years, she has led Clinical Advice Services in Patient Experience as Medical Director, developing evidence- and consensus-based clinical decision support for clinical triage across 30+ medical and surgical subspecialties and 200+ clinics (~1 million calls/year). Under her leadership, this award-winning service has built a strong track record in patient safety, reduced unnecessary ED and clinic visits, and reduced pages to on-call teams by over 90%. She also served as Chief of Surgical Co-management for Neurosurgery, ENT, and Orthopedic Surgery, Co-Director of Clinical Research in Hospital Medicine, and Physician Lead of Stanford Health Care's Readmissions Committee.
Dr. Rohatgi has authored peer-reviewed articles in high-impact journals (NEJM, Lancet, JAMA, Nature, Annals of Surgery) and book chapters in Perioperative Medicine, and has served as principal investigator and co-investigator for NIH and industry-sponsored trials. She is Editor-in-Chief of JMIR Perioperative Medicine and serves on the Editorial Board of Brown University's Journal of Hospital Medicine. A global advisor on surgical co-management models, she chaired the Society of Hospital Medicine's Global Technical Advisory Committee on co-management and has served on multiple national committees in research, quality and patient safety, perioperative medicine, and practice management. Recognized as a Top Hospitalist by the American College of Physicians, she has received numerous national and international awards for clinical care, quality improvement, teaching, and research, and has been an invited faculty and keynote speaker at regional, national, and international meetings.
Her unique lens spans clinical experience managing patients in medical and surgical specialties, research on millions of patient records, clinical trials, patient experience, clinical triage, and health system operations. Dr. Rohatgi is passionate about innovative, value-based, sustainable solutions and exploring new frontiers in healthcare. -
Rajat Rohatgi
Professor of Biochemistry and of Medicine (Oncology)
Current Research and Scholarly Intereststhe overall goal of my laboratory is to uncover new regulatory mechanisms in signaling systems, to understand how these mechanisms are damaged in disease states, and to devise new strategies to repair their function.
-
Benjamin Rolles
Postdoctoral Scholar, Hematology
BioMD/Research Fellow
@MullallyLab @StanfordMed @VAPaloAlto @BrighamHeme @BrighamResearch @HarvardMed
Studied
@UniklinikAachen @RWTH
Interested in MPN & Myeloid Malignancies
